Stevens Capital Management LP Penumbra Inc Transaction History

Stevens Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$253.22 - $299.78 $243,344 - $288,088	961 New	961 $247,000
Q1 2019 May 03, 2019	SELL	$115.84 - $160.31 $647,198 - $895,651	-5,587 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$113.42 - $156.48 $633,677 - $874,253	5,587 New	5,587 $683,000
Q3 2018 Nov 13, 2018	SELL	$121.55 - $156.8 $2.92 Million - $3.77 Million	-24,064 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$112.2 - $165.95 $103,785 - $153,503	925 Added 4.0%	24,064 $3.32 Million

Q1 2018 May 08, 2018	BUY	$84.6 - $126.1 $1.96 Million - $2.92 Million	23,139 New	23,139 $2.68 Million

473

30.6M

309K

95.9K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $10.6B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.